Lars Englberger
Overview
Explore the profile of Lars Englberger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stortecky S, Barco S, Windecker S, Heg D, Kadner A, Englberger L, et al.
Eur J Cardiothorac Surg
. 2024 Jul;
66(1).
PMID: 38991831
Objectives: We hypothesized that ultrasound-assisted thrombolysis (USAT) is non-inferior to surgical pulmonary embolectomy (SPE) to improve right ventricular (RV) function in patients with acute pulmonary embolism (PE). Methods: In a...
2.
Amstad T, Taeymans J, Englberger L, Mohacsi P, Steiner D, Wilhelm M, et al.
J Cardiopulm Rehabil Prev
. 2021 Nov;
42(2):97-102.
PMID: 34753874
Purpose: The aim of this study was to investigate changes in exercise capacity (EC) and quality of life (QoL) of patients with ventricular assist devices (VADs) during cardiac rehabilitation (CR)....
3.
Corpataux N, Brugger N, Winkel M, Pilgrim T, Englberger L, Windecker S, et al.
JACC Cardiovasc Interv
. 2020 Nov;
14(1):e5-e7.
PMID: 33248983
No abstract available.
4.
Russmann S, Rahmany A, Niedrig D, Hatz K, Ludin K, Burden A, et al.
Eur J Clin Pharmacol
. 2020 Nov;
77(5):709-716.
PMID: 33242107
Purpose: The antiplatelet prodrug clopidogrel is bioactivated by the polymorphic enzyme CYP2C19. Prospective clinical studies demonstrated an association between CYP2C19 loss of function (LoF) variants and an increased risk of...
5.
Gisler V, Durr S, Irincheeva I, Limacher A, Droz S, Carrel T, et al.
J Am Coll Cardiol
. 2020 Jul;
76(1):31-40.
PMID: 32616160
Background: Bacterial growth in cultures of resected heart valves of patients with infective endocarditis (IE) is influenced by pre-operative antibiotic treatment (preop-AT). Objectives: This study sought to evaluate the time...
6.
Pfortmueller C, Kindler M, Schenk N, Messmer A, Hess B, Jakob L, et al.
Intensive Care Med
. 2020 Jun;
46(9):1683-1695.
PMID: 32519005
Purpose: Recent evidence questions a liberal approach to fluid resuscitation in intensive care unit (ICU) patients. Here, we assess whether use of hypertonic saline applied as single infusion at ICU...
7.
Gisler F, Spinetti T, Erdoes G, Luedi M, Pfortmueller C, Messmer A, et al.
Medicine (Baltimore)
. 2020 Apr;
99(15):e19580.
PMID: 32282706
Introduction: Infective endocarditis (IE) and other severe infections induce significant changes in the immune response in a considerable number of affected patients. Numerous IE patients develop a persistent functional immunological...
8.
Roost E, Weber A, Alberio L, Englberger L, Reineke D, Keller D, et al.
Thromb Res
. 2019 Dec;
186:1-6.
PMID: 31837559
Background: Patients with mechanical heart valves are still not eligible for treatment with direct oral anticoagulants (DOAC). We aimed to conduct a proof-of-principle study investigating the anti-Xa inhibitor rivaroxaban as...
9.
Tevaeara Stahel H, Barandun S, Kaufmann E, Gahl B, Englberger L, Jenni H, et al.
J Thorac Dis
. 2019 Jul;
11(Suppl 10):S1471-S1479.
PMID: 31293796
Background: Cardioplexol™ with its low volume (100 mL) was originally conceived as cardioplegic solution for MiECC procedures. Introduced in its current form in 2008 in our clinic, it has immediately...
10.
Pfortmueller C, Messmer A, Hess B, Reineke D, Jakob L, Wenger S, et al.
Trials
. 2019 Jun;
20(1):357.
PMID: 31200756
Background: Intraoperative and postoperative management of cardiac surgery patients is complex, involving the application of differential vasopressors and volume therapy. It has been shown that a positive fluid balance has...